Vijai Muthu, Baba Mursaleen, Ramalingam Satish, Thiyagaraj Anand
Department of Genetic Engineering, SRM Institute of Science and Technology, Sri Ramaswamy Memorial (SRM) Nagar, Kattankulathur, Tamil Nadu 603203, India.
Oncol Lett. 2021 Dec;22(6):850. doi: 10.3892/ol.2021.13111. Epub 2021 Oct 26.
Doublecortin-like kinase protein 1 (DCLK1) is a microtubule-associated protein with a C-terminal serine/threonine kinase domain. Its expression was first reported in radial glial cells, where it serves an essential role in early neurogenesis, and since then, other functions of the DCLK1 protein have also been identified. Initially considered to be a marker of quiescent gastrointestinal and pancreatic stem cells, DCLK1 has recently been identified in the gastrointestinal tract as a marker of tuft cells. It has also been implicated in different types of cancer, where it regulates several vital pathways, such as Kras signaling. However, its underlying molecular mechanisms remain unclear. The present review discusses the different roles of DCLK1 and its interactions with other proteins that are homologically similar to DCLK1 to develop a novel therapeutic strategy to target cancer cells more accurately.
双皮质素样激酶蛋白1(DCLK1)是一种与微管相关的蛋白,其C端具有丝氨酸/苏氨酸激酶结构域。它最初在放射状胶质细胞中被报道,在早期神经发生中发挥重要作用,从那时起,DCLK1蛋白的其他功能也已被确定。DCLK1最初被认为是静止的胃肠道和胰腺干细胞的标志物,最近在胃肠道中被确定为簇状细胞的标志物。它还与不同类型的癌症有关,在这些癌症中它调节多种重要途径,如Kras信号传导。然而,其潜在的分子机制仍不清楚。本综述讨论了DCLK1的不同作用及其与其他与DCLK1同源相似的蛋白的相互作用,以制定一种更准确地靶向癌细胞的新治疗策略。